NO20074278L - Tigecyklinblandinger og fremgangsmater for fremstilling - Google Patents

Tigecyklinblandinger og fremgangsmater for fremstilling

Info

Publication number
NO20074278L
NO20074278L NO20074278A NO20074278A NO20074278L NO 20074278 L NO20074278 L NO 20074278L NO 20074278 A NO20074278 A NO 20074278A NO 20074278 A NO20074278 A NO 20074278A NO 20074278 L NO20074278 L NO 20074278L
Authority
NO
Norway
Prior art keywords
tigecycline
methods
mixtures
preparation
preparations
Prior art date
Application number
NO20074278A
Other languages
English (en)
Norwegian (no)
Inventor
Mahdi Bakir Fawzi
Syed Muzafar Shah
Tianmin Zhu
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36648809&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20074278(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of NO20074278L publication Critical patent/NO20074278L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20074278A 2005-03-14 2007-08-22 Tigecyklinblandinger og fremgangsmater for fremstilling NO20074278L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US66103005P 2005-03-14 2005-03-14
PCT/US2006/008827 WO2006099258A1 (en) 2005-03-14 2006-03-13 Tigecycline compositions and methods of preparation

Publications (1)

Publication Number Publication Date
NO20074278L true NO20074278L (no) 2007-11-20

Family

ID=36648809

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074278A NO20074278L (no) 2005-03-14 2007-08-22 Tigecyklinblandinger og fremgangsmater for fremstilling

Country Status (25)

Country Link
US (5) US7879828B2 (pt)
EP (1) EP1858488B2 (pt)
JP (1) JP4972081B2 (pt)
KR (2) KR20130122988A (pt)
CN (2) CN101132775A (pt)
AR (2) AR053827A1 (pt)
AU (1) AU2006223226B2 (pt)
BR (1) BRPI0608464A2 (pt)
CA (1) CA2602089C (pt)
CR (1) CR9416A (pt)
CY (1) CY1114504T1 (pt)
DK (1) DK1858488T4 (pt)
ES (1) ES2434944T5 (pt)
GT (1) GT200600112A (pt)
HN (1) HN2006011218A (pt)
IL (1) IL185924A (pt)
MX (1) MX2007010983A (pt)
NO (1) NO20074278L (pt)
PE (1) PE20061107A1 (pt)
PL (1) PL1858488T5 (pt)
PT (1) PT1858488E (pt)
RU (1) RU2428190C2 (pt)
TW (1) TW200700092A (pt)
WO (1) WO2006099258A1 (pt)
ZA (1) ZA200707831B (pt)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1858488B2 (en) 2005-03-14 2022-07-20 Wyeth LLC Tigecycline compositions and methods of preparation
AR057649A1 (es) * 2005-05-27 2007-12-12 Wyeth Corp Formas solidas cristalinas de tigeciclina y metodos para preparar las mismas
AR055336A1 (es) * 2005-06-16 2007-08-22 Wyeth Corp Proeso de elaboracion para la produccion de tigeciclina como un polvo reconstituible, polvo de tigeciclina liofilizado y producto hecho mediante el proceso
US7645789B2 (en) 2006-04-07 2010-01-12 Vertex Pharmaceuticals Incorporated Indole derivatives as CFTR modulators
US20070244335A1 (en) * 2006-04-17 2007-10-18 Teva Pharmaceutical Industries Ltd. Isolation of tetracycline derivatives
ES2622356T3 (es) * 2006-04-24 2017-07-06 Teva Pharmaceutical Industries, Ltd. Formas cristalinas de tigeciclina y procesos para su preparación
US8198470B2 (en) * 2006-04-24 2012-06-12 Teva Pharmaceutical Industries Ltd. Crystalline form II of tigecycline and processes for preparation thereof
FR2910812B1 (fr) 2006-12-29 2009-03-20 Pierre Fabre Medicament Sa Compositions pharmaceutiques injectables lyophilisees de derives hemi-synthetiques d'alcaloide de vinca stables a temperature ambiante
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
US9107929B2 (en) 2008-05-01 2015-08-18 Ranbaxy Laboratories Limited Stable parenteral formulations of tigecycline
WO2010017273A2 (en) * 2008-08-06 2010-02-11 Wyeth Tigecycline formulations
CN102138925B (zh) * 2010-01-29 2014-06-25 正大天晴药业集团股份有限公司 替加环素组合物及其制备方法
PT2568987T (pt) 2010-05-12 2017-02-03 Rempex Pharmaceuticals Inc Composições de tetraciclina
WO2012169435A1 (ja) 2011-06-07 2012-12-13 旭化成ファーマ株式会社 高純度ｐｔｈ含有凍結乾燥製剤およびその製造方法
CN102391148B (zh) * 2011-10-24 2014-01-08 江苏奥赛康药业股份有限公司 一种高纯度替加环素的合成方法
CN103315947B (zh) 2012-03-22 2016-01-20 上海汇伦生命科技有限公司 一种注射用替加环素组合物
CN103356662B (zh) * 2012-03-27 2015-11-25 浙江医药股份有限公司新昌制药厂 注射用替加环素组合物及其制备方法
CN102641249A (zh) * 2012-05-06 2012-08-22 江苏奥赛康药业股份有限公司 一种替加环素组合物的制备方法
CN103417498B (zh) * 2012-05-18 2017-09-12 山东新时代药业有限公司 一种替加环素冻干粉针剂的制备方法
CN102697739B (zh) * 2012-05-31 2014-10-29 丽珠医药集团股份有限公司 一种减少替加环素差向异构体化的粉针剂制备方法
CN102911077B (zh) * 2012-11-12 2015-01-07 成都百裕科技制药有限公司 4r-替加环素的制备方法
IN2013MU01127A (pt) * 2013-03-26 2015-05-01 Astron Res Ltd
WO2014167575A2 (en) * 2013-03-26 2014-10-16 Astron Research Limited Stable tigecycline composition
CN104107170A (zh) * 2013-04-22 2014-10-22 上海汇伦生命科技有限公司 一种替加环素组合物
US20140323443A1 (en) * 2013-04-30 2014-10-30 Fresenius Kabi Usa, Llc Tigecycline formulations
US20160143925A1 (en) 2013-11-12 2016-05-26 Galenicum Health S.L. Stable pharmaceutical compositions
NO2723977T3 (pt) 2014-03-19 2018-03-10
CN105079816B (zh) * 2015-08-17 2018-09-07 江苏豪森药业集团有限公司 替加环素药物组合物及其制备方法
CN108653216B (zh) * 2018-05-28 2020-12-18 福安药业集团湖北人民制药有限公司 注射用替加环素
WO2021063468A1 (en) 2019-10-02 2021-04-08 Anfarm Hellas S.A. Stable parenteral pharmaceutical composition containing tigecycline and process for the preparation thereof
CN113582870A (zh) * 2020-05-01 2021-11-02 复旦大学附属华山医院 一种恢复替加环素抗菌活性的方法
IT202100031133A1 (it) 2021-12-13 2023-06-13 Zambon Spa Composizione farmaceutica comprendente tigeciclina

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH225704A (de) 1942-01-06 1943-02-15 Schlotterbeck Automobile Aktie Holzgasgenerator.
GB901107A (en) 1959-06-29 1962-07-11 Pfizer Therapeutic composition and method of preparing same
US3026248A (en) 1959-09-11 1962-03-20 Pfizer & Co C Thioglycerol and formaldehyde sulfoxylate stabilized tetracycline antibiotics in polyhydric alcohol solvents
US3106512A (en) 1961-07-19 1963-10-08 Olin Mathieson Stabilization of tetracycline base in dry form with glucono delta lactone
US3145228A (en) 1962-09-06 1964-08-18 Pfizer & Co C 5-alkoxy-and 5-benzyloxy-tetracycline, derivatives and analogues thereof
US3219529A (en) 1962-10-04 1965-11-23 American Cyanamid Co Stable tetracycline solutions
US4038315A (en) 1972-05-11 1977-07-26 American Cyanamid Company Isolation and recovery of calcium chloride complex of 7-dimethylamino-6-dimethyl l-6-deoxytetracycline hydrochloride
DE2748132A1 (de) 1977-10-27 1979-05-03 Behringwerke Ag Stabilisator fuer polysaccharid
US4457916A (en) 1982-08-31 1984-07-03 Asahi Kasei Kogyo Kabushiki Kaisha Method for stabilizing Tumor Necrosis Factor and a stable aqueous solution or powder containing the same
US4678812A (en) 1986-05-30 1987-07-07 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5122519A (en) 1989-06-27 1992-06-16 American Cyanamid Company Stable, cosmetically acceptable topical gel formulation and method of treatment for acne
EP0779603B1 (en) 1990-06-22 2002-03-27 Canon Kabushiki Kaisha Image processing apparatus
US5494903A (en) 1991-10-04 1996-02-27 American Cyanamid Company 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
US5538954A (en) 1994-06-24 1996-07-23 A/S Dumex (Dumex Ltd.) Salts of tetracyclines
US5675030A (en) * 1994-11-16 1997-10-07 American Cyanamid Company Method for selective extracting a 7-(hydrogen or substituted amino)-9- (substituted glycyl) amido!-6-demethyl-6-deoxytetracycline compound
US6503881B2 (en) * 1996-08-21 2003-01-07 Micrologix Biotech Inc. Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics
US5908838A (en) 1998-02-19 1999-06-01 Medics Pharmaceutical Corporation Method for the treatment of acne
EP1212050B1 (en) 1999-09-14 2006-12-06 Mucosal Therapeutics LLC Formulations containing tetracyclines for treating or preventing mucositis
WO2002012170A1 (en) 2000-08-04 2002-02-14 Trustees Of Tufts College 8-substituted tetracycline compounds
EP1360316A2 (en) 2001-01-11 2003-11-12 Board of Regents, The University of Texas System Dosage adjustement for antibiotics
EP1401402B1 (en) 2001-05-29 2016-09-07 Takeda Pharmaceuticals U.S.A., Inc. Enhancement of oral bioavailability of non-emulsified formulation of cefditoren pivoxil with lecithin
EP2327409A1 (en) 2001-07-13 2011-06-01 Paratek Pharmaceuticals, Inc. Tetracycline compound having target therapeutic activities
US20030171340A1 (en) 2002-02-07 2003-09-11 Jenefir Isbister Methods of disease treatment using metal-complexed tetracycline antibiotics
CN1390550A (zh) * 2002-07-25 2003-01-15 于航 盐酸米诺环素冻干粉针剂及其制备方法
CA2503446C (en) 2002-10-24 2012-12-18 Paratek Pharmaceuticals, Inc. Methods of using substituted tetracycline compounds to modulate rna
WO2004078111A2 (en) 2003-03-06 2004-09-16 Ranbaxy Laboratories Limited Extended release minocycline compositions and processes for their preparation
CN1568999A (zh) † 2003-07-14 2005-01-26 南宁枫叶药业有限公司 稳定的医药用河豚毒素冷冻干燥制剂
US20050148553A1 (en) 2003-09-05 2005-07-07 Testa Raymond T. Use of tigecycline, alone, or in combination with rifampin to treat osteomyelitis and/or septic arthritis
GB2414668B (en) 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
ATE415973T1 (de) 2004-10-28 2008-12-15 Wyeth Corp Gemeinsame gabe von tigecyclin und digoxin
EP1858488B2 (en) 2005-03-14 2022-07-20 Wyeth LLC Tigecycline compositions and methods of preparation
AR057034A1 (es) 2005-05-27 2007-11-14 Wyeth Corp Metodos para purificar tigeciclina
EP3003273A1 (en) † 2013-05-31 2016-04-13 Xellia Pharmaceuticals ApS A method for stabilizing tigecycline

Also Published As

Publication number Publication date
JP2008533146A (ja) 2008-08-21
KR20130122988A (ko) 2013-11-11
DK1858488T4 (da) 2022-09-12
DK1858488T3 (da) 2013-11-04
EP1858488B1 (en) 2013-09-11
EP1858488B2 (en) 2022-07-20
JP4972081B2 (ja) 2012-07-11
US9694078B2 (en) 2017-07-04
GT200600112A (es) 2006-11-29
AU2006223226B2 (en) 2012-03-15
PT1858488E (pt) 2013-11-18
ZA200707831B (en) 2011-02-23
PL1858488T5 (pl) 2024-01-03
US20110118216A1 (en) 2011-05-19
AR109500A2 (es) 2018-12-19
ES2434944T3 (es) 2013-12-18
CA2602089A1 (en) 2006-09-21
US10588975B2 (en) 2020-03-17
US20160144036A1 (en) 2016-05-26
TW200700092A (en) 2007-01-01
US8975242B2 (en) 2015-03-10
PL1858488T3 (pl) 2014-01-31
CN101132775A (zh) 2008-02-27
IL185924A0 (en) 2008-01-06
US7879828B2 (en) 2011-02-01
HN2006011218A (es) 2008-09-17
CR9416A (es) 2008-03-06
KR20080002828A (ko) 2008-01-04
KR101354093B1 (ko) 2014-01-24
RU2007131396A (ru) 2009-04-20
AU2006223226A1 (en) 2006-09-21
CA2602089C (en) 2013-04-30
IL185924A (en) 2014-05-28
WO2006099258A8 (en) 2007-10-04
ES2434944T5 (es) 2022-10-20
WO2006099258A1 (en) 2006-09-21
BRPI0608464A2 (pt) 2010-01-05
US20060247181A1 (en) 2006-11-02
CY1114504T1 (el) 2016-10-05
MX2007010983A (es) 2007-09-19
RU2428190C2 (ru) 2011-09-10
CN102512429A (zh) 2012-06-27
EP1858488A1 (en) 2007-11-28
AR053827A1 (es) 2007-05-23
US20150141379A1 (en) 2015-05-21
PE20061107A1 (es) 2006-12-08
US20170266290A1 (en) 2017-09-21
US9254328B2 (en) 2016-02-09

Similar Documents

Publication Publication Date Title
NO20074278L (no) Tigecyklinblandinger og fremgangsmater for fremstilling
NO20054185D0 (no) Methods of radiofluorination of biologically active vectors
DK1898721T3 (da) Fremgangsmåde til fremstilling af en vandig suspension og et pulverformigt præparat af et eller flere carotioider
NZ798475A (en) Prefusion-stabilized hmpv f proteins
NO20074093L (no) Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav
BR112012032999A8 (pt) Hidrolisado lignocelulósico e métodos de hidrólise ácida e desacidificação para gerar misturas de açúcar a partir de lignocelulose
ES2353814T3 (es) Proteinas n-glicosiladas recombinantes de celulas procariotas.
HRP20110567T1 (en) Process for manufacturing vaccines
AR059772A1 (es) Composiciones que incuyen hemaglutinina metodos de elaboracion y metodos de uso de las mismas
BRPI0515649A (pt) processo para preparação de composições de anticorpos altamente concentradas e processo para concentrar proteìnas
WO2009137624A3 (en) Hemangio colony forming cells and non-engrafting hemangio cells
BR122021020829B8 (pt) Proteína de ligação ao fator h de ocorrência não natural (fhbp), composição, e célula hospedeira de neisseria meningitidis geneticamente modificada
NO20064584L (no) Tetrahydropyridoindolderivater
NO20080129L (no) Fremgangsmate for fremstilling av dihydrokinazoliner
NO20066055L (no) Pyridinderivater
ECSP056111A (es) Derivados de 2-acilamino-4-feniltiazol, su preparación y aplicación en terapeutica
CL2008003794A1 (es) Virus de la estomatitis vesicular geneticamente modificado (vsv) que comprende por lo menos una mutacion de aminoacido en una region de alguna de las proteinas m, g y l del virus; metodo para producirlo; composicion inmunogenica que lo comprende; metodo para adaptar un virus en un cultivo celular.
GB2453068A (en) Novel hepatocyte-like cells and hepatoblast-like cells derived from hbs cells
WO2008036932A3 (en) Compositions and methods comprising boswellia species
MX2010001849A (es) Depsipeptidos ciclicos.
NO20076391L (no) Sammensetninger og metoder for behandling av tilstander relatert til efrinsignaler med cupredoxin
NO20091990L (no) Substituerte pyrazoler, sammensetninger inneholdende disse, fremgangsmate for fremstilling og anvendelse
BR112015013071A2 (pt) solução de trombina e seus métodos de uso
CL2011000941A1 (es) Composicion adecuada para la administracion oral a un animal que comprende una enzima reductora del estres inmunologico alfa-mananasa; y su uso para mejorar el rendimiento del crecimiento del animal y/o reducir el estres inmunologico del mismo (div. sol. n°3527-06).
DK1688146T3 (da) Fremstilling af aldesleukin til farmaceutisk anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application